Document is current
Any future updates will be listed below
-
Authors
Hatoko, Tomonobu
Harada, Norio
Tokumoto, Shinsuke
Yamane, Shunsuke
Ikeguchi-Ogura, Eri
Kato, Tomoko
Yasuda, Takuma
Tatsuoka, Hisato
Shimazu-Kuwahara, Satoko
Yabe, Daisuke
Hayashi, Yoshitaka
Inagaki, Nobuya
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (19K09022)
Japan Society for the Promotion of Science (20H03731)
Japan Diabetes Foundation
Suzuken Memorial Foundation
Japan Association for Diabetes Education and Care
MSD Life Science Foundation, Public Interest Incorporated Foundation
Ministry of Education, Culture, Sports, Science and Technology
Ministry of Health, Labour and Welfare
Ministry of Agriculture, Forestry and Fisheries
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 17 October 2022
First Online: 20 October 2022
Competing interests
: N. I. received joint research grants from Daiichi Sankyo Co., Ltd., Terumo Co., Ltd., and Drawbridge, Inc.; N.I. received speaker honoraria from Kowa Pharmaceutical Co., Ltd.; MSD, Astellas Pharma Inc., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma Co., Ltd.; N.I. received scholarship grants from Kissei Pharmaceutical Co., Ltd., Sanofi, Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Japan Tobacco Inc., Kyowa Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Astellas Pharma Inc., MSD, Eli Lilly Japan, Ono Pharmaceutical Co. Ltd., Sanwa Kagaku Kenkyusho Co. Ltd., Nippon Boehringer Ingelheim Co., Ltd., Novo Nordisk Pharma Ltd., Novartis Pharma K.K., Teijin Pharma Ltd., and Life Scan Japan Inc.. N. H. received scholarship grants from Mitsubishi Tanabe Pharma Co., Ltd., Ono Pharmaceutical Co. Ltd., Sanofi, and Novo Nordisk Pharma Ltd. All other authors have nothing to disclose.
